Published in Clin Cancer Res on November 01, 1998
Red cells coated with immunoglobulin G: binding and sphering by mononuclear cells in man. Science (1967) 6.42
The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol (1996) 3.82
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med (2001) 3.81
Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercocebus atys). Proc Natl Acad Sci U S A (1986) 3.76
HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat Med (1998) 3.61
Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14. Nature (1990) 3.54
Surgery for a fractured femur and elective ICU admission at 113 yr of age. Br J Anaesth (2000) 3.41
An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol (1998) 3.32
Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes. Science (1991) 3.12
Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells. J Clin Invest (1981) 2.97
Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene (1990) 2.97
Inhibitor of neurite outgrowth in humans. Nature (2000) 2.89
Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology Group. N Engl J Med (1998) 2.85
Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees. Nature (1987) 2.82
A novel loop-loop recognition motif in the yeast ribosomal protein L30 autoregulatory RNA complex. Nat Struct Biol (1999) 2.80
Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome. J Virol (1986) 2.65
Human granulocyte generation of hydroxyl radical. J Exp Med (1978) 2.54
Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J Virol (1996) 2.52
Structural mosaicism on the submicron scale in the plasma membrane. Biophys J (1998) 2.50
Phagocyte-generated oxygen metabolites and cellular injury. Lab Invest (1982) 2.43
Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO J (1997) 2.43
Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. J Clin Oncol (1999) 2.36
Blood clearance rates of adenovirus type 5 in mice. J Gen Virol (2000) 2.36
Unexplained fitting in three parturients suffering from postdural puncture headache. Br J Anaesth (2002) 2.34
Vascular access for haemodialysis. Br J Surg (2000) 2.27
Neuropilin-2 is required in vivo for selective axon guidance responses to secreted semaphorins. Neuron (2000) 2.25
Rapid, nonradioactive detection of mutations in the human genome by allele-specific amplification. J Lab Clin Med (1989) 2.22
Characterization of glass adherent human mononuclear cells. J Immunol (1973) 2.22
Human blood monocytes: stimulators of granulocyte and mononuclear colony formation in vitro. Science (1972) 2.21
Laparoscopy-assisted sigmoid resection. Surg Laparosc Endosc (1991) 2.18
Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. Proc Natl Acad Sci U S A (1989) 2.15
Targeted gene delivery by tropism-modified adenoviral vectors. Nat Biotechnol (1996) 2.14
Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J Virol (1996) 2.12
Long-term results of arteriovenous fistulas using transposed autologous basilic vein. Br J Surg (2000) 2.12
Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc Natl Acad Sci U S A (1998) 2.11
Spectrum of disease in macaque monkeys chronically infected with SIV/SMM. Vet Immunol Immunopathol (1989) 2.09
Drosophila wingless and pair-rule transcripts localize apically by dynein-mediated transport of RNA particles. Cell (2001) 2.06
Localization of iodine-125-mIP-Des-Met14-bombesin (7-13)NH2 in ovarian carcinoma induced to express the gastrin releasing peptide receptor by adenoviral vector-mediated gene transfer. J Nucl Med (1997) 2.05
Alternative splicing generates a secreted form of N-CAM in muscle and brain. Cell (1988) 1.97
Effects of corticosteroid therapy on human monocyte function. N Engl J Med (1975) 1.96
CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. Gene Ther (2001) 1.92
Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma. J Urol (2001) 1.92
High-efficiency receptor-mediated delivery of small and large (48 kilobase gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles. Proc Natl Acad Sci U S A (1992) 1.90
Replicative adenoviruses for cancer therapy. Nat Biotechnol (2000) 1.89
Anaemia in pregnancy in southern Malawi: prevalence and risk factors. BJOG (2000) 1.88
Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J Virol (1998) 1.88
Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer. J Clin Oncol (2001) 1.87
Evidence for hydroxyl radical generation by human Monocytes. J Clin Invest (1977) 1.85
Season of birth predicts mortality in rural Gambia. Nature (1997) 1.85
Neural cell adhesion molecule (NCAM) is the antigen recognized by monoclonal antibodies of similar specificity in small-cell lung carcinoma and neuroblastoma. Int J Cancer (1989) 1.85
Morphoregulatory activities of NCAM and N-cadherin can be accounted for by G protein-dependent activation of L- and N-type neuronal Ca2+ channels. Cell (1991) 1.85
Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo. Nat Biotechnol (2001) 1.83
A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes. Virology (1993) 1.83
Human muscle neural cell adhesion molecule (N-CAM): identification of a muscle-specific sequence in the extracellular domain. Cell (1987) 1.81
Effects of corticosteroids on human monocyte function. J Clin Invest (1974) 1.81
Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology (1993) 1.79
Early programming of adult diseases in resource poor countries. Arch Dis Child (2005) 1.77
Ischaemic preconditioning in transplantation and major resection of the liver. Br J Surg (2005) 1.73
Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc Natl Acad Sci U S A (1992) 1.72
The natural history of infection with the lymphadenopathy-associated virus/human T-lymphotropic virus type III. Ann Intern Med (1985) 1.71
Molecular basis of defective anion transport in L cells expressing recombinant forms of CFTR. Hum Mol Genet (1993) 1.71
Birth season and environmental influences on patterns of thymic growth in rural Gambian infants. Acta Paediatr (2003) 1.69
An iatrogenic arterial foreign body. Br J Anaesth (1996) 1.68
Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector. Nat Biotechnol (1997) 1.66
Comparison of the effects of propofol and isoflurane anaesthesia on right ventricular function and shunt fraction during thoracic surgery. Br J Anaesth (1995) 1.62
Characterization of infectivity of knob-modified adenoviral vectors in glioma. Cancer Biol Ther (2008) 1.61
Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. Cancer Res (1998) 1.59
Kidney damage during organ recovery in donation after circulatory death donors: data from UK National Transplant Database. Am J Transplant (2012) 1.59
Induction of specific T-cell tolerance by adenovirus-transfected, Fas ligand-producing antigen presenting cells. Nat Biotechnol (1998) 1.59
A potential role for hypochlorous acid in granulocyte-mediated tumor cell cytotoxicity. Blood (1980) 1.59
Use of chlorotoxin for targeting of primary brain tumors. Cancer Res (1998) 1.59
A distinct African lentivirus from Sykes' monkeys. J Virol (1993) 1.58
Physiological values and procedures in the 24 h before ICU admission from the ward. Anaesthesia (1999) 1.58
CFTR activation: additive effects of stimulatory and inhibitory phosphorylation sites in the R domain. Am J Physiol (1997) 1.57
Survival rates of tropical and temperate passerines: a Trinidadian perspective. Am Nat (1997) 1.53
A case-control comparison of the results of renal transplantation from heart-beating and non-heart-beating donors. Transplantation (2001) 1.52
Blood volume redistribution during cross-clamping of the descending aorta. Anesth Analg (1994) 1.52
The alpha 1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy. Chest (1989) 1.51
Stress and dominance in a social fish. J Neurosci (1997) 1.51
Phase I trial of iodine-131-chimeric B72.3 (human IgG4) in metastatic colorectal cancer. J Nucl Med (1992) 1.49
Cadmium-binding component in Escherichia coli during accommodation to low levels of this ion. Appl Environ Microbiol (1981) 1.49
Targeted eradication of ovarian cancer mediated by intracellular expression of anti-erbB-2 single-chain antibody. Gynecol Oncol (1995) 1.47
Neurite outgrowth in response to transfected N-CAM and N-cadherin reveals fundamental differences in neuronal responsiveness to CAMs. Neuron (1991) 1.46
A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency. Clin Cancer Res (2001) 1.43
Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin. J Virol (2001) 1.43
Addition of a short peptide ligand to the adenovirus fiber protein. Gene Ther (1995) 1.42
Liver damage during organ donor procurement in donation after circulatory death compared with donation after brain death. Br J Surg (2012) 1.42
Preparation of specific ribosomal RNA fragments. Methods Enzymol (1988) 1.41
High-level expression of fully active yeast flavocytochrome b2 in Escherichia coli. Biochem J (1989) 1.41
Determination of the gene sequence and the three-dimensional structure at 2.4 angstroms resolution of methanol dehydrogenase from Methylophilus W3A1. J Mol Biol (1996) 1.41
Transcribed genes are localized according to chromosomal position within polarized Drosophila embryonic nuclei. Curr Biol (1999) 1.40
Enhanced myogenesis in NCAM-transfected mouse myoblasts. Nature (1990) 1.39
Components of saliva inactivate human immunodeficiency virus. Lancet (1986) 1.39
Alternated versus syncopated CHOP-PVB: two studies for the treatment of non-Hodgkin's lymphoma by the Southwest Oncology Group. Cancer Invest (1991) 1.39
A system for the propagation of adenoviral vectors with genetically modified receptor specificities. Nat Biotechnol (1999) 1.39
Iron status in pregnant women: which measurements are valid? Br J Haematol (1998) 1.39
Vaginal transmission of human immunodeficiency virus (HIV) to a chimpanzee. J Infect Dis (1986) 1.38
Adenoviral vector infection of the human exocrine pancreas. Arch Surg (1997) 1.38